immun
system
evolv
protect
multicellular
organ
includ
human
pathogen
immunostimulatori
effect
regulatori
action
counteract
reduc
immun
respons
caus
immunodefici
diseas
viral
infect
malnutrit
tumor
age
two
strategi
develop
stimul
immun
system
one
method
increas
antigenspecif
nonspecif
immun
respons
method
involv
use
appropri
immunosuppl
antigen
administr
respiratori
virus
among
infecti
pathogen
human
mani
differ
occur
kind
pathogen
antigen
worldwid
infect
pattern
recent
respiratori
diseas
middl
east
respiratori
syndrom
sever
acut
respiratori
syndrom
flu
caus
novel
swineorigin
influenza
strain
emerg
begun
spread
rapidli
associ
respiratori
virus
show
strong
tendenc
spread
grow
interest
food
promot
immun
function
well
global
monitor
system
influenza
result
sever
research
reveal
posit
correl
food
nutrit
control
human
immun
function
variou
food
recogn
function
food
improv
immun
function
food
materi
may
deriv
veget
seafood
mushroom
microb
lactic
acid
bacteria
chitosan
peptid
deriv
yeast
cell
wall
modul
mani
vivo
vitro
activ
main
immunopharmacolog
activ
associ
antitumor
effect
increas
host
resist
viral
bacteri
parasit
infect
adjuv
effect
proxim
composit
extracellular
polysaccharid
aureobasidium
pullulan
carbohydr
sugar
crude
protein
moistur
name
proxim
composit
polysaccharid
small
amount
protein
fat
person
comm
dr
dongchan
park
report
extracellular
polysaccharid
isol
aureobasidium
pullulan
pullulan
exopolysaccharid
ep
aubasidan
side
chain
howev
physiolog
activ
polysaccharid
produc
aureobasidium
pullulan
mainli
studi
exopolym
purifi
aureobasidium
pullulan
eap
solubl
water
test
food
materi
use
studi
contain
use
food
shown
potent
immunomodulatori
activ
mous
model
addit
eap
show
advers
event
clinic
studi
design
evalu
effect
bone
metabol
improv
atop
dermat
therefor
consid
safe
human
ingest
mani
report
describ
immunomodulatori
activ
immunerel
diseas
report
describ
effect
cold
flu
reason
clinic
studi
perform
evalu
efficaci
safeti
aureobasidium
pullulan
cold
flu
patient
studi
select
adult
subject
provid
written
inform
consent
particip
satisfi
select
criteria
meet
exclus
criteria
randomli
administ
eap
placebo
subject
took
daili
dosag
mg
week
evalu
immunolog
improv
test
food
observ
function
chang
immun
system
administ
test
food
materi
eap
placebo
group
also
observ
durat
total
level
cold
flu
symptom
test
period
eap
placebo
product
use
clinic
research
studi
packag
insid
box
provid
glucan
co
ltd
busan
korea
suppli
distribut
aribio
co
ltd
seongnamsi
gyeonggido
korea
eap
sampl
deposit
herbarium
silla
univers
busan
korea
encod
sixtyf
capsul
provid
subject
take
consider
dosag
day
capsul
visit
window
day
capsul
storag
product
capsul
test
food
manufactur
marooncolor
hard
capsul
capsul
test
food
contain
mg
eap
mg
microcrystallin
cellulos
wherea
placebo
food
contain
mg
microcrystallin
cellulos
test
food
suppli
test
agenc
seal
white
plastic
bottl
contain
capsul
intend
person
test
food
use
studi
ident
appear
descript
would
difficult
distinguish
nake
eye
experi
conduct
doubleblind
format
subject
research
attach
ident
label
test
food
main
ingredi
gener
name
lot
number
record
test
food
label
avoid
expos
differ
test
group
subject
took
eap
hard
capsul
daili
week
empti
stomach
suffici
amount
water
subject
includ
studi
meet
follow
criteria
adult
year
age
individu
white
blood
cell
wbc
count
individu
could
monitor
throughout
test
period
individu
listen
thorough
explan
studi
purpos
content
voluntarili
sign
inform
consent
form
particip
experi
subject
follow
criteria
applic
exclud
experi
individu
bodi
mass
index
bmi
individu
exceed
normal
maximum
alanin
transaminas
aspart
transaminas
level
femal
pregnant
breastfeed
femal
childbear
age
agre
use
contracept
via
medic
proven
method
eg
condom
lubric
femidom
test
period
individu
fast
plasma
dextros
concentr
mgdl
individu
high
blood
pressur
systol
blood
pressur
mm
hg
diastol
blood
pressur
mm
hg
individu
continu
use
medicin
could
affect
effect
assess
hyperlipidemia
medicin
steroid
medicin
hormon
medicin
immunosuppress
antibiot
individu
requir
continu
treatment
psychiatr
disord
anorexia
depress
manic
depress
individu
system
diseas
immunityrel
diseas
seriou
hepat
renal
insuffici
malign
tumor
pulmonari
diseas
collagenosi
multipl
sclerosi
allerg
skin
condit
autoimmun
diseas
individu
medic
histori
drug
clinic
signific
allerg
reaction
individu
histori
gastrointestin
disord
could
affect
absorpt
test
food
histori
gastrointestin
surgeri
exclud
simpl
appendectomi
hernia
oper
individu
consum
medicin
herbal
medicin
within
month
particip
experi
could
affect
immun
individu
particip
differ
human
studi
clinic
test
took
experiment
product
within
month
particip
experi
exclud
human
studi
cosmet
individu
research
otherwis
determin
might
difficulti
complet
experi
dosag
experiment
product
temporarili
suspend
instanc
appropri
stop
experi
welfar
subject
follow
case
administr
test
food
temporarili
suspend
temporari
interrupt
occurr
advers
reaction
treatment
advers
reaction
b
show
advers
event
relat
safeti
test
food
c
case
show
acut
reaction
allergi
hypersensit
test
food
howev
case
temporari
interrupt
occurr
advers
reaction
treatment
advers
reaction
problem
complianc
studi
continu
case
process
dropout
includ
test
food
alloc
subject
legal
repres
withdrew
consent
particip
experi
case
result
final
inspect
could
obtain
case
subject
adher
test
protocol
result
signific
effect
test
result
case
interrupt
contact
subject
ie
subject
could
trace
case
subject
fail
make
visit
subject
diseas
discov
went
unnot
screen
inspect
case
complianc
usag
test
food
fell
assess
usag
log
case
without
direct
research
subject
use
medicin
product
take
test
food
could
affect
research
result
interpret
data
case
subject
averag
weekli
drink
quantiti
ethanol
gweek
throughout
test
period
case
lead
research
determin
research
proceed
inappropri
could
signific
effect
safeti
subject
experi
result
subject
stop
take
test
food
process
dropout
follow
reason
possibl
continu
human
studi
case
seriou
advers
event
occur
subject
case
advers
event
made
particip
experi
imposs
case
research
determin
usag
observ
test
food
would
impertin
case
clinic
test
possibl
due
death
subject
emerg
diseas
subject
took
test
food
later
drop
studi
portion
entir
estim
valu
final
assess
visit
omit
includ
itt
group
analysi
data
miss
valu
process
dropout
occur
use
miss
valu
process
method
effect
assess
result
subject
drop
exclud
assess
per
protocol
pp
group
figur
tabl
experi
subject
maintain
regular
level
drink
diet
exercis
similar
level
prior
particip
experi
verifi
day
base
evalu
examin
dietari
content
contigu
day
prior
visit
day
weekli
exercis
type
time
prior
visit
day
number
alcohol
drink
amount
ethanol
consum
week
prior
visit
day
also
examin
subject
kept
daili
record
whether
consum
test
food
record
contigu
day
diet
includ
saturday
sunday
exercis
alcohol
drink
test
food
consumpt
record
chart
provid
test
agenc
comparison
made
quantiti
prior
particip
experi
observ
made
whether
chang
could
significantyl
affect
experi
result
subject
assign
eap
group
group
take
eap
placebo
group
group
take
placebo
base
random
list
produc
random
sampl
tabl
gener
use
microsoft
excel
microsoft
window
figur
exclus
criteria
use
select
subject
screen
visit
visit
verifi
individu
met
select
criteria
met
exclus
criteria
select
subject
studi
food
materi
alloc
subject
visit
subject
select
experi
issu
subject
number
order
visit
made
visit
provid
test
food
randomli
alloc
food
use
human
test
provid
particip
subject
base
process
describ
human
test
protocol
tabl
studi
protocol
approv
institut
review
board
irb
daegu
korean
medicin
hospit
daegu
korea
irb
procedur
perform
accord
ethic
standard
declar
helsinki
good
clinic
practic
guidelin
visit
date
allow
set
base
visit
day
addit
day
select
test
subject
receiv
test
food
within
day
base
evalu
date
select
inspect
date
began
take
test
food
next
morn
demograph
data
includ
initi
age
gender
birthdat
weight
height
subject
basic
inform
medic
histori
medicin
intak
histori
combin
treatment
concomit
drug
smoke
drink
exercis
habit
record
detail
content
last
year
record
medic
histori
content
last
week
record
medicin
intak
histori
type
exercis
exercis
time
examin
week
prior
time
visit
day
diet
exercis
compar
base
evalu
period
experiment
period
observ
determin
whether
import
chang
occur
could
affect
test
result
number
quantiti
alcohol
drink
consum
week
preced
visit
day
examin
inform
convert
number
gram
ethanol
consum
record
blood
pressur
bodi
temperatur
puls
measur
record
vital
sign
obes
level
measur
use
bodi
fat
analyz
inbodi
biospac
korea
bmi
percent
bodi
fat
waisthip
ratio
viscer
fat
area
record
hematolog
examin
wbc
red
blood
cell
hemoglobin
level
hematocrit
platelet
perform
use
autom
analyz
sysmex
sysmex
kobe
japan
level
blood
urea
nitrogen
creatinin
uric
acid
total
bilirubin
albumin
total
protein
alkalin
phosphatas
glucos
alanin
transaminas
aspart
transaminas
gammaglutamyl
transferas
triglycerid
total
cholesterol
highdens
lipoprotein
cholesterol
lowdens
lipoprotein
cholesterol
measur
use
clinic
chemistri
analyz
dimens
xpand
plu
siemen
munich
germani
urin
sampl
store
dark
analyz
within
two
hour
collect
ph
specif
graviti
protein
glucos
level
measur
use
semiautom
analyz
uriscan
pro
ii
yd
diagnost
seoul
korea
pregnanc
test
perform
use
kit
detect
human
chorion
gonadotropin
serum
concentr
cytokin
analyz
use
hmaglxsa
plex
multiplex
elisa
kit
r
system
minneapoli
mn
cytokin
level
determin
use
luminex
luminex
austin
tx
usa
data
report
median
fluoresc
intens
immun
function
improv
diseas
durat
symptom
level
decreas
due
increas
resist
viral
diseas
cold
flu
accordingli
examin
durat
level
cold
flu
symptom
consum
test
food
product
function
index
immunolog
improv
survey
follow
administr
test
food
form
provid
subject
made
daili
record
health
condit
daili
record
test
food
dosag
nine
symptom
monitor
inspect
health
condit
subject
survey
fever
chill
runni
nose
nasal
congest
cough
sneez
sore
throat
headach
gastrointestin
symptom
nausea
vomit
diarrhea
abdomin
pain
subject
mark
symptom
exist
symptom
record
symptom
level
subject
use
score
point
system
mark
symptom
minor
symptom
moder
symptom
seriou
symptom
mark
whether
took
earli
leav
absent
work
school
due
symptom
tabl
show
detail
explan
criteria
use
report
symptom
level
assess
effect
experiment
food
product
subject
kept
daili
record
dosag
log
cold
flu
symptom
durat
symptom
level
test
period
complianc
ingest
test
food
evalu
base
foodusag
log
final
visit
number
remain
food
collect
compar
usag
log
record
case
differ
record
actual
amount
food
taken
complianc
verifi
differ
small
primari
effect
assess
variabl
includ
durat
total
score
symptom
level
cold
influenza
secondari
effect
assess
variabl
includ
serum
level
well
wbc
count
differenti
blood
count
target
evalu
includ
subject
taken
even
food
use
human
studi
visit
least
one
time
safeti
data
term
advers
event
vital
sign
valu
chang
clinic
examin
valu
procur
subject
evalu
term
predict
side
effect
advers
event
advers
drug
reaction
abnorm
chang
clinic
examin
valu
vital
sign
comparison
made
side
effect
advers
drug
reaction
manifest
frequenc
advers
event
causeandeffect
relationship
test
food
predict
occur
eap
placebo
group
differ
group
analyz
perform
chisquar
test
fisher
exact
test
statist
analysi
assess
effect
test
food
base
statist
guidelin
clinic
trial
statist
packag
use
sa
version
microsoft
window
statist
signific
level
set
word
statist
signific
p
valu
signific
probabl
statist
analysi
perform
focus
signific
comparison
eap
placebo
group
methodolog
describ
follow
detail
analysi
analysi
set
obtain
test
subject
compos
larg
itt
analysi
group
pp
analysi
group
itt
group
compris
primari
data
set
use
effect
assess
pp
group
addit
analyz
assess
effect
subject
itt
group
includ
taken
test
food
materi
whose
assess
variabl
measur
least
visit
subject
pp
group
includ
itt
group
complet
test
accord
studi
protocol
item
baselin
homogen
test
test
group
gender
age
weight
height
obes
alcohol
drink
consumpt
exercis
smoke
item
prepost
food
ingest
homogen
test
within
test
group
weight
height
alcohol
drink
ingest
exercis
item
effect
test
durat
symptom
level
cold
flu
symptom
serum
level
wbc
differenti
blood
count
observ
item
clinic
laboratori
test
item
homogen
test
carri
eap
placebo
group
baselin
observ
item
prior
ingest
test
food
studi
chisquar
method
conduct
categori
variabl
fisher
exact
test
perform
cell
expect
frequenc
less
homogen
test
continu
variabl
independ
ttest
conduct
addit
analyt
method
employ
use
homogen
test
investig
whether
weight
obes
alcohol
drink
ingest
exercis
could
affect
test
result
due
chang
lifestyl
habit
test
period
predict
fewer
subject
contract
viral
diseas
cold
flu
immun
function
enhanc
durat
level
symptom
decreas
one
diseas
contract
activ
state
princip
cell
relat
immun
determin
measur
chang
serum
content
cytokin
assess
effect
test
food
materi
signific
mean
differ
visit
test
variabl
includ
effect
test
word
statist
comparison
made
averag
variat
food
ingest
eap
placebo
group
end
normal
test
evalu
data
parametr
method
twosampl
ttest
chosen
normal
satisfi
wherea
nonparametr
method
wilcoxon
ranksum
test
chosen
normal
satisfi
addit
signific
test
perform
mean
differ
eap
placebo
group
visit
test
food
ingest
analyz
preval
cold
symptom
subject
record
durat
level
symptom
contract
cold
flu
prior
ingest
test
food
visit
subject
record
durat
total
symptom
score
cold
influenza
symptom
test
period
accordingli
meaning
compar
mean
differ
visit
consid
rate
scale
use
visit
differ
word
confirm
homogen
test
group
visit
evalu
effect
compar
result
test
group
visit
itt
group
analysi
often
conduct
last
observ
carri
forward
locf
method
singleimput
method
data
miss
final
effect
assess
typic
locf
method
easi
use
clinic
trial
despit
restrict
assumpt
miss
data
treat
constant
locf
method
commonli
use
provid
conserv
result
howev
commonli
recommend
methodolog
process
miss
valu
studi
statist
analyt
data
collect
compris
baselin
assess
prior
ingest
test
food
materi
final
assess
ingest
test
food
materi
miss
valu
final
assess
replac
base
assess
valu
substitut
averag
group
assess
studi
screen
individu
voluntarili
agre
particip
human
studi
subject
met
select
criteria
meet
exclusionari
criteria
enrol
among
subject
assign
eap
group
assign
placebo
group
figur
four
instanc
verifi
subject
violat
studi
protocol
consum
test
food
subject
process
dropout
among
subject
select
individu
eap
group
drop
due
violat
visit
schedul
shortfal
complianc
individu
placebo
group
drop
due
withdraw
inform
consent
shortfal
complianc
remain
subject
adher
test
protocol
complet
test
current
state
dropout
separ
accord
test
group
figur
complianc
ingest
test
food
materi
assess
visit
content
record
daili
record
fill
subject
well
quantiti
remain
product
return
final
visit
confirm
assess
complianc
calcul
use
follow
formula
complianc
number
food
materi
ingestednumb
food
materi
ingest
number
food
materi
ingest
number
food
materi
provid
number
food
materi
return
subject
whose
complianc
set
dropout
dropout
studi
due
complianc
shortfal
complianc
test
food
materi
ingest
eap
group
placebo
group
signific
differ
complianc
test
group
observ
tabl
homogen
test
conduct
test
group
follow
measur
valu
prior
food
materi
ingest
regard
demograph
inform
subject
includ
age
gender
medic
histori
treatment
histori
medic
histori
concomit
medic
measur
valu
ingest
food
materi
regard
item
could
affect
test
result
base
chang
lifestyl
habit
test
period
includ
regular
exercis
smoke
drink
result
preliminari
investig
age
gender
medic
histori
treatment
histori
medic
histori
concomit
medic
exercis
smoke
drink
among
subject
summar
tabl
signific
differ
found
test
group
regard
item
examin
result
ttest
perform
evalu
signific
differ
group
ingest
test
food
materi
verifi
durat
cold
symptom
p
valu
cold
symptom
level
p
valu
visit
signific
signific
level
statist
analysi
also
show
differ
occur
test
group
prior
ingest
food
materi
visit
durat
cold
symptom
experi
group
day
lower
placebo
group
day
differ
test
group
statist
signific
p
valu
eap
group
also
lower
score
cold
symptom
level
placebo
group
versu
resp
differ
signific
level
p
valu
figur
signific
differ
visit
verifi
respect
mean
differ
measur
item
visit
time
assess
effect
test
food
materi
blood
test
result
result
significantli
differ
eap
placebo
group
tabl
signific
level
wbc
basophil
lymphocyt
count
follow
normal
nonparametr
wilcoxon
ranksum
test
conduct
result
significantli
differ
eap
placebo
group
tabl
signific
level
assess
effect
test
food
materi
ttest
conduct
evalu
signific
differ
mean
cytokin
concentr
visit
result
significantli
differ
eap
placebo
group
tabl
signific
level
valu
satisfi
normal
nonparametr
statist
wilcoxon
ranksum
test
conduct
reveal
signific
differ
item
signific
level
tabl
advers
event
observ
individu
placebo
group
individu
eap
group
placebo
group
nausea
pruritu
confirm
subject
asthenopia
rash
subject
sore
throat
subject
advers
event
observ
asid
eap
group
headach
confirm
subject
advers
event
confirm
asid
advers
event
subsid
within
day
case
subject
ingest
test
food
materi
headach
complet
allevi
day
subject
judg
causeandeffect
relationship
ingest
test
food
materi
data
shown
studi
abnorm
chang
clinic
test
result
examin
item
blood
biochem
result
exceed
normal
rang
ingest
test
food
materi
result
demonstr
chang
valu
individu
placebo
group
well
chang
serum
glutam
oxaloacet
transaminas
sgot
serum
glutam
pyruv
transaminas
sgpt
triglycerid
tg
valu
individu
experi
group
placebo
group
subject
demonstr
valu
visit
iul
exceed
normal
rang
similar
visit
iul
determin
unrel
ingest
test
food
materi
valu
exhibit
decreas
trend
eap
group
tg
valu
subject
increas
mgdl
visit
mgdl
visit
result
prior
ingest
test
food
materi
also
outsid
normal
rang
determin
unrel
ingest
test
food
materi
differ
confirm
visit
regard
abnorm
chang
clinic
test
result
sgot
sgpt
valu
subject
exceed
normal
rang
visit
visit
howev
base
train
lectur
titl
assess
abnorm
liver
function
test
korean
societi
health
promot
diseas
prevent
academi
famili
medicin
sgotsgpt
ratio
fall
sgot
sgpt
exce
normal
upper
limit
find
consid
repres
abnorm
phenomenon
howev
valu
found
abnorm
high
visit
subject
examin
result
show
abnorm
valu
relat
ingest
test
food
materi
instead
result
due
excess
drink
subject
consum
alcohol
drink
frequent
daysweek
high
quantiti
ethanol
averag
gweek
data
shown
occurr
advers
event
abnorm
chang
clinic
test
result
item
found
correl
use
test
food
materi
suspect
correl
thu
test
food
found
safe
context
studi
variou
biolog
activ
verifi
vitro
test
anim
test
clinic
trial
recent
effect
respiratori
diseas
studi
rodent
human
preval
increas
rapidli
eap
exopolym
purifi
aureobasidium
pullulan
contain
use
test
food
shown
potent
immunomodulatori
activ
mous
model
howev
studi
first
evalu
use
eap
respiratori
diseas
assess
abil
eap
improv
human
immunolog
respons
allevi
cold
flu
symptom
adult
age
year
white
blood
cell
count
x
screen
individu
enrol
subject
satisfi
select
criteria
fall
exclus
criteria
data
shown
aspect
subject
respiratori
morbid
none
subject
respiratori
diseas
time
enrol
within
week
prior
screen
date
subject
subject
light
respiratori
diseas
confirm
symptom
enrol
subject
proceed
obtain
inform
consent
subject
administr
test
food
period
week
randomli
assign
either
eap
placebo
group
blood
test
survey
cold
flu
symptom
conduct
ingest
test
food
materi
durat
symptom
level
cold
flu
well
result
blood
test
cytokin
analysi
compar
eap
placebo
group
compos
individu
exhibit
homogen
show
statist
signific
differ
complianc
ingest
test
food
gender
age
complianc
regular
exercis
smoke
drink
medic
histori
medicin
histori
concomit
drug
administr
clinic
data
shown
immunitypromot
function
prevent
acut
respiratori
infect
cold
influenza
virus
reduc
frequenc
contract
cold
flu
symptom
level
symptom
durat
base
effect
criteria
studi
statist
analysi
durat
level
cold
symptom
primari
variabl
assess
effect
show
differ
assess
valu
eap
placebo
group
ingest
test
food
materi
howev
durat
cold
flu
symptom
ingest
test
food
materi
significantli
lower
eap
group
placebo
group
signific
level
eap
group
also
show
lower
level
cold
flu
symptom
statist
differ
signific
level
placebo
group
predict
individu
whose
immun
function
enhanc
contract
fewer
viral
diseas
cold
flu
reduc
durat
level
symptom
activ
state
primari
cell
relat
immun
determin
measur
serum
level
cytokin
accord
guidelin
safeti
efficaci
assess
function
food
immun
function
improv
ministri
food
drug
safeti
korea
chang
cytokin
level
wbc
count
cell
count
nk
cell
activ
peripher
blood
measur
determin
function
immun
reinforc
human
studi
secondari
variabl
includ
serum
cytokin
wbc
neutrophil
eosinophil
basophil
lymphocyt
monocyt
assess
effect
exhibit
statist
signific
differ
ingest
test
food
materi
signific
level
result
consist
choi
et
al
daili
intak
level
eap
polycantm
placebo
food
materi
set
mg
chang
serum
cytokin
studi
intent
observ
effect
immun
improv
eap
statist
signific
chang
found
although
eap
shown
potent
immunomodulatori
activ
mous
model
immun
improv
eap
human
observ
studi
cytokin
factor
need
chang
suddenli
accord
individu
health
condit
return
normal
rang
normal
rang
blood
cytokin
concentr
individu
variat
larg
thu
larg
number
subject
requir
measur
normal
rang
cytokin
concentr
inde
studi
normal
korean
cytokin
level
subject
studi
studi
normal
american
cytokin
level
subject
examin
estim
normal
rang
blood
cytokin
concentr
serval
studi
shown
chang
blood
cytokin
level
observ
follow
ingest
multivitamin
miner
supplement
probiot
supplement
fish
oil
cordycep
militari
known
help
improv
immun
may
cytokin
level
increas
test
period
return
normal
number
subject
small
indic
individu
deviat
rang
statist
signific
studi
total
number
subject
test
group
control
group
respect
therefor
result
studi
may
statist
overcom
individu
variat
rang
subject
cytokin
level
due
small
number
subject
research
need
extens
clinic
studi
clear
statist
number
confirm
effect
eap
plasma
cytokin
signific
advers
event
occur
period
test
food
materi
intak
advers
event
exclud
cold
observ
individu
placebo
group
nausea
pruritu
asthenopia
rash
sore
throat
individu
experi
group
headach
advers
event
subsid
within
day
determin
causeandeffect
relationship
ingest
test
food
materi
chang
blood
test
valu
also
observ
eap
group
increas
sgpt
tg
valu
difficult
determin
clinic
abnorm
addit
aspect
respiratori
morbid
subject
suffer
cold
test
period
appear
fulli
cure
treatment
respiratori
morbid
shown
subject
therefor
eap
verifi
harmless
human
bodi
collect
data
reveal
eap
associ
statist
signific
decreas
durat
cold
flu
symptom
primari
variabl
assess
effect
although
cold
symptom
level
differ
signific
level
cold
flu
symptom
level
eap
group
less
sever
compar
placebo
group
statist
signific
chang
observ
serum
cytokin
concentr
wbc
differenti
blood
count
secondari
variabl
assess
effect
therefor
data
show
eap
use
medicin
function
food
materi
prevent
treat
cold
flu
